Skip to content

4Accepted Oct 7, 4:24 PM ET

Clorox Co: CEO Linda Rendle received 29,352 shares

CLXCLOROX CO /DE/

Accepted (ET)

4:24 PM

Oct 7, 2026

Filed

Oct 7, 2026

Documents

1

Size

8.0 KB

Summary

Clorox Co: CEO Linda Rendle received 29,352 shares

Updated

What happened

  • Linda J. Rendle, CEO, received an award of 29,352 shares on Oct 5, 2026 at $80.41 per share for a total value of $2,360,194. On the same date 692 shares and 11,989 shares were disposed at $80.41 per share for $55,644 and $964,035 respectively to satisfy payment/tax obligations. The net increase in shares from these transactions is 16,671 shares.
  • The filing notes that 3,679 of the acquired shares were from a dividend reinvestment feature and that the award was the settlement of a 2023 performance unit grant that vested on Oct 5, 2026 and was elected to be deferred.

Key details

  • Transaction date and prices: Oct 5, 2026; acquisition 29,352 shares at $80.41 ($2,360,194); disposals 692 shares at $80.41 ($55,644) and 11,989 shares at $80.41 ($964,035).
  • Shares owned after the transaction: not disclosed in the filing.
  • Relevant footnotes: F1 settlement of 2023 performance unit grant that vested 10/5/26 and was elected to be deferred; F2 and F3 withholding of shares to satisfy tax obligations for vesting of performance and restricted stock; F4 includes 3,679 shares from dividend reinvestment.
  • Filing date: Oct 7, 2026. No late filing indicated.

Why it may matter

  • The filing shows vesting and settlement of performance stock units and withholding of shares to satisfy tax liabilities rather than an open-market sale.
  • This filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing